Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
about
The curious origins of angioimmunoblastic T-cell lymphomaTHZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitorsThe Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target.Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomasBCL6 as a therapeutic target for lymphoma.
P2860
Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Selective targeting of BCL6 in ...... ing to BCL2 in B-cell lymphoma
@en
Selective targeting of BCL6 in ...... ng to BCL2 in B-cell lymphoma.
@nl
type
label
Selective targeting of BCL6 in ...... ing to BCL2 in B-cell lymphoma
@en
Selective targeting of BCL6 in ...... ng to BCL2 in B-cell lymphoma.
@nl
prefLabel
Selective targeting of BCL6 in ...... ing to BCL2 in B-cell lymphoma
@en
Selective targeting of BCL6 in ...... ng to BCL2 in B-cell lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Selective targeting of BCL6 in ...... ing to BCL2 in B-cell lymphoma
@en
P2093
Alka Malik
Ari Melnick
Jayeshkumar Patel
John Leonard
Katerina Hatzi
Peter Martin
Shao Ning Yang
Thibault Dupont
P2860
P304
P356
10.18632/ONCOTARGET.6513
P407
P577
2015-12-09T00:00:00Z